Maya is currently President, U.S. Pharmaceuticals, for GSK, where she leads a $20+ billion pharmaceuticals and vaccines businesses in the U.S. and Puerto Rico.
Previously, Maya served as President of the Biopharma Latin America business for Merck KGaA, Darmstadt, Germany, where she used her proven expertise to drive pharmaceutical business in developed and emerging markets. At Merck KGaA, she oversaw business in 14 countries with more than 1,000 employees while guiding the region’s strategy for continued business growth by both delivering the company’s planned medical launches and further developing its core healthcare business. Maya also led the Regional Leadership Team, where she worked closely with General Managers and heads of regional functions and served as a member of the International Operations Leadership Team.
Maya had joined Merck KGaA in 2016 as Senior Vice President and Head of Global Oncology for the biopharma business. Aside from leading the Bavencio* worldwide launch, she supported Merck’s transformation to a recognized global oncology innovator. She played a critical role in establishing collaborations to strengthen Merck’s presence in the oncology field, including making significant contributions to the alliance with Pfizer.
Prior to joining Merck KGaA, Maya worked at Pfizer, Inc. as a senior executive for over a decade. At Pfizer, she exercised her vast cross-border, regional and global leadership experience to boost sales growth and market penetration in the areas of oncology, vaccines and specialty portfolios. In her last role, Maya oversaw the company’s oncology business in the U.S., managing a large-scale cross-functional team and leading product introductions and launches across multiple tumor types.
Maya holds her M.S. in business leadership and marketing from the IE Business Institute in Madrid, Spain, and a B.A. in Communications from Saint Louis University.
* Trademarks are property of their respective owners.